Combination strategies of immunotherapy in breast cancer
Prof Guiseppe Curigliano - European Institute of Oncology, Milan, Italy
Combination strategies of immunotherapy in breast cancer ( Prof Guiseppe Curigliano - European Institute of Oncology, Milan, Italy )
26 Oct 2018
SOLO1: Maintenance olaparib in advanced BRCA ovarian cancer
Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA
SOLO1: Maintenance olaparib in advanced BRCA ovarian cancer ( Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA )
26 Oct 2018
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic pr...
Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic profiling of tissue and circulating tumour DNA ( Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah )
25 Oct 2018
The standard of care and progress so far with PARP inhibitors for ovarian cancer
Dr Susana Banerjee - The Institute of Cancer Research, London, UK
The standard of care and progress so far with PARP inhibitors for ovarian cancer ( Dr Susana Banerjee - The Institute of Cancer Research, London, UK )
25 Oct 2018
Comment on the Every Woman Study
Clara MacKay - World Ovarian Cancer Coalition, Canada
Comment on the Every Woman Study ( Clara MacKay - World Ovarian Cancer Coalition, Canada )
24 Oct 2018
ESMO 2018: Highlights
Prof Gordon McVie , Will Davies
ESMO 2018: Highlights ( Prof Gordon McVie , Will Davies )
22 Oct 2018
The past, present and future of treating ovarian cancer
Dr Susana Banerjee - The Institute of Cancer Research, London, UK
The past, present and future of treating ovarian cancer ( Dr Susana Banerjee - The Institute of Cancer Research, London, UK )
21 Oct 2018
Comment on SOLO-1 for advanced ovarian cancer
Dr Jonathan Ledermann - University College London, London, UK
Comment on SOLO-1 for advanced ovarian cancer ( Dr Jonathan Ledermann - University College London, London, UK )
21 Oct 2018
Olaparib improves progression free survival up front in ovarian cancer
Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA
Olaparib improves progression free survival up front in ovarian cancer ( Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA )
21 Oct 2018
Preventing ovarian cancer through early excision of tubes and late ovarian remov...
Dr Ranjit Manchanda - Barts Cancer Institute, London, UK
Preventing ovarian cancer through early excision of tubes and late ovarian removal ( Dr Ranjit Manchanda - Barts Cancer Institute, London, UK )
27 Jul 2018
Population-wide testing for cancer-associated mutations
Dr Ranjit Manchanda - Barts Cancer Institute, London, UK
Population-wide testing for cancer-associated mutations ( Dr Ranjit Manchanda - Barts Cancer Institute, London, UK )
27 Jul 2018
Should HIPEC be part of standard care in the UK?
Dr Ranjit Manchanda - Barts Cancer Institute, London, UK
Should HIPEC be part of standard care in the UK? ( Dr Ranjit Manchanda - Barts Cancer Institute, London, UK )
27 Jul 2018